Proposed Data Collection Submitted for Public Comment and Recommendations, 48146-48147 [2021-18541]
Download as PDF
<![CDATA[
48146
Federal Register / Vol. 86, No. 164 / Friday, August 27, 2021 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Health care providers ......................................
Study screener ...............................................
Web-based survey .........................................
Exploratory Guide—Prevention with Positives
In-depth Interview.
Exploratory Guide—Patient Centered Care
In-depth Interview.
Exploratory Guide—HIV Prevention In-depth
Interview.
Message Testing In-depth Interview Guide ...
Concept Testing In-depth Interview Guide ....
Materials Testing In-depth Interview ..............
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–18540 Filed 8–26–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–21–0600; Docket No. CDC–2021–
0087]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
ACTION:
Notice with comment period.
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled CDC Model Performance
Evaluation Program (MPEP) for
Mycobacterium tuberculosis
Susceptibility Testing information
collection. CDC is requesting a threeyear approval for revision to the
previously approved project used to
monitor and evaluate performances and
practices among national laboratories
for M. tuberculosis susceptibility
testing.
SUMMARY:
lotter on DSK11XQN23PROD with NOTICES1
Number of
respondents
Type of respondent
VerDate Sep<11>2014
17:52 Aug 26, 2021
Jkt 253001
CDC must receive written
comments on or before October 26,
2021.
DATES:
You may submit comments,
identified by Docket No. CDC–2021–
0087 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
ADDRESSES:
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
(in hours)
1,138
569
95
1
1
1
10/60
15/60
1
95
1
1
95
1
1
95
95
95
1
1
1
1
1
1
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
CDC Model Performance Evaluation
Program (MPEP) for Mycobacterium
tuberculosis Susceptibility testing (OMB
Control No. 0920–0600, Exp. 2/20/
2022)—Revision—National Center for
HIV/AIDS, Viral Hepatitis, STD, and TB
Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC) is requesting a
revision to approved information
collection from participants in the CDC
Model Performance for Mycobacterium
tuberculosis Drug Susceptibility Testing
Program for a period of three years.
Revision of this information will not
E:\FR\FM\27AUN1.SGM
27AUN1
48147
Federal Register / Vol. 86, No. 164 / Friday, August 27, 2021 / Notices
Participants in this program include
domestic clinical and public health
laboratories. Data collection from
laboratory participants occurs twice per
year. The data collected in this program
will include the susceptibility test
results of primary and secondary drugs,
drug concentrations, and test methods
performed by laboratories on a set of
performance evaluation (PE) isolates.
The PE isolates are sent to participants
twice a year, and participants also
report demographic data such as
laboratory type and the number of drug
susceptibility tests performed annually.
CDC requests approval for an
estimated 129 burden hours annually.
There is no cost to respondents to
participate other than their time.
for Mycobacterium tuberculosis
susceptibility testing is used to monitor
and evaluate performance and practices
among US laboratories performing M.
tuberculosis susceptibility testing.
Participation in this program is one way
laboratories can ensure high-quality
laboratory testing, resulting in accurate
and reliable testing results.
By providing an evaluation program
to assess the ability of laboratories to
test for drug resistant M. tuberculosis
strains, CDC gives laboratories a selfassessment tool to aid in optimizing
their skills in susceptibility testing. The
information obtained from the
laboratories on susceptibility practices
and procedures is used to establish
variables related to good performance,
assess training needs, and aid with the
development of practice standards.
require changes in the scope of the
project. This Revision includes; (a)
modification of the Instructions to
Participants Letter; (b) modification of
the MPEP Mycobacterium tuberculosis
Results Worksheet; (c) modification of
online data collection instrument; (d)
modification of the MPEP
Mycobacterium tuberculosis Minimum
Inhibitory Concentration Results
Worksheet; (e) removal of Reminder
Telephone Script; and (f) modification
of Aggregate Report Letter.
While the overall number of cases of
TB in the U.S. has decreased, rates still
remain high among foreign-born
persons, corrections, homeless
populations, and individuals infected
with HIV in major metropolitan areas.
To reach the goal of eliminating TB, the
Model Performance Evaluation Program
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Domestic Laboratory .....
Participant Biosafety Compliance Letter of
Agreement.
MPEP Mycobacterium tuberculosis Results
Worksheet.
Online Survey Instrument ....................................
MPEP Mycobacterium tuberculosis Minimum Inhibitory Concentration Results Form.
Total ........................
..............................................................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–18541 Filed 8–26–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Health Statistics
(BSC, NCHS)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
lotter on DSK11XQN23PROD with NOTICES1
ACTION:
Notice of meeting.
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Board of Scientific Counselors,
National Center for Health Statistics
BSC, NCHS). This meeting is open to
the public.
SUMMARY:
VerDate Sep<11>2014
17:52 Aug 26, 2021
Jkt 253001
Number of
responses per
respondent
Number of
respondents
Type of respondents
1
5/60
7
80
2
30/60
80
80
4
2
2
15/60
15/60
40
2
........................
........................
........................
129
The meeting will be held on
October 22, 2021, from 11:00 a.m. to
5:30 p.m., EDT.
ADDRESSES: Instructions to access the
meeting are posted on the BSC website:
https://www.cdc.gov/nchs/about/bsc/
bsc_meetings.htm.
FOR FURTHER INFORMATION CONTACT:
Rebecca Hines, M.H.S., Executive
Secretary, NCHS/CDC, Board of
Scientific Counselors, 3311 Toledo
Road, Room 2627, Hyattsville, Maryland
20782, Telephone: (301) 458–4717;
Email: RSHines@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Board is charged with
providing advice and making
recommendations to the Secretary,
Department of Health and Human
Services; the Director, CDC; and the
Director, NCHS, regarding the scientific
and technical program goals and
objectives, strategies, and priorities of
NCHS.
Matters To Be Considered: The
meeting agenda includes welcome
remarks and a Center update by the
NCHS Director; updates on Data
Modernization (DMI), including
Epidemiology and Laboratory Capacity
Frm 00034
Fmt 4703
Total burden
(in hours)
80
DATES:
PO 00000
Average
burden per
response
(in hours)
Sfmt 4703
for Prevention and Control of Emerging
Infectious Diseases (ELC) Collaboration;
an update on the National Center for
Health Statistics Strategic Planning;
presentation on the NCHS Health Equity
Strategy; updates on using the National
Health Interview Survey (NHIS) as a
platform for additional data collection;
and an update on several NCHS
Programs. Agenda items are subject to
change as priorities dictate.
Meeting Information: Please visit the
BSC website: https://www.cdc.gov/nchs/
about/bsc/bsc_meetings.htm for more
information on the meeting agenda,
including instructions for accessing the
live meeting broadcast.
The Board will reserve time for public
comment at the end of the day.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
E:\FR\FM\27AUN1.SGM
27AUN1
]]>Agencies
[Federal Register Volume 86, Number 164 (Friday, August 27, 2021)]
[Notices]
[Pages 48146-48147]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-18541]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-21-0600; Docket No. CDC-2021-0087]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled CDC Model Performance Evaluation
Program (MPEP) for Mycobacterium tuberculosis Susceptibility Testing
information collection. CDC is requesting a three-year approval for
revision to the previously approved project used to monitor and
evaluate performances and practices among national laboratories for M.
tuberculosis susceptibility testing.
DATES: CDC must receive written comments on or before October 26, 2021.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0087 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
CDC Model Performance Evaluation Program (MPEP) for Mycobacterium
tuberculosis Susceptibility testing (OMB Control No. 0920-0600, Exp. 2/
20/2022)--Revision--National Center for HIV/AIDS, Viral Hepatitis, STD,
and TB Prevention (NCHHSTP), Centers for Disease Control and Prevention
(CDC).
Background and Brief Description
The Centers for Disease Control and Prevention (CDC) is requesting
a revision to approved information collection from participants in the
CDC Model Performance for Mycobacterium tuberculosis Drug
Susceptibility Testing Program for a period of three years. Revision of
this information will not
[[Page 48147]]
require changes in the scope of the project. This Revision includes;
(a) modification of the Instructions to Participants Letter; (b)
modification of the MPEP Mycobacterium tuberculosis Results Worksheet;
(c) modification of online data collection instrument; (d) modification
of the MPEP Mycobacterium tuberculosis Minimum Inhibitory Concentration
Results Worksheet; (e) removal of Reminder Telephone Script; and (f)
modification of Aggregate Report Letter.
While the overall number of cases of TB in the U.S. has decreased,
rates still remain high among foreign-born persons, corrections,
homeless populations, and individuals infected with HIV in major
metropolitan areas. To reach the goal of eliminating TB, the Model
Performance Evaluation Program for Mycobacterium tuberculosis
susceptibility testing is used to monitor and evaluate performance and
practices among US laboratories performing M. tuberculosis
susceptibility testing. Participation in this program is one way
laboratories can ensure high-quality laboratory testing, resulting in
accurate and reliable testing results.
By providing an evaluation program to assess the ability of
laboratories to test for drug resistant M. tuberculosis strains, CDC
gives laboratories a self-assessment tool to aid in optimizing their
skills in susceptibility testing. The information obtained from the
laboratories on susceptibility practices and procedures is used to
establish variables related to good performance, assess training needs,
and aid with the development of practice standards.
Participants in this program include domestic clinical and public
health laboratories. Data collection from laboratory participants
occurs twice per year. The data collected in this program will include
the susceptibility test results of primary and secondary drugs, drug
concentrations, and test methods performed by laboratories on a set of
performance evaluation (PE) isolates. The PE isolates are sent to
participants twice a year, and participants also report demographic
data such as laboratory type and the number of drug susceptibility
tests performed annually.
CDC requests approval for an estimated 129 burden hours annually.
There is no cost to respondents to participate other than their time.
Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
--------------------------------------------------------------------------------------------------------------------------------------------------------
Domestic Laboratory............................ Participant Biosafety Compliance Letter 80 1 5/60 7
of Agreement.
MPEP Mycobacterium tuberculosis Results 80 2 30/60 80
Worksheet.
Online Survey Instrument............... 80 2 15/60 40
MPEP Mycobacterium tuberculosis Minimum 4 2 15/60 2
Inhibitory Concentration Results Form.
---------------------------------------------------------------
Total...................................... ....................................... .............. .............. .............. 129
--------------------------------------------------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-18541 Filed 8-26-21; 8:45 am]
BILLING CODE 4163-18-P
